PubMed HealthSearch

PubMed · 324705

Automatic data processing in the cardiac catheterization laboratory.

Abstract

A review of automatic data processing in the cardiac catherization lab is presented. The emphasis placed on on-line manometry, indicator dilution and off-line quantitative ventriculography. The system organization is described and several specific examples given to illustrate the level of detail necessary to specify such a system. The clinical use of the system is described together with an evaluation of the original design goals in terms of the actual performance of the system. A few unexpected benefits have emerged with respect to quality control and reliability, but one of the original design goals, speeding up the catheterization procedure, has proven to be unrealistic. The next logical steps in the software and hardware evolution are described with the emphasis placed on making the system a more effective tool for the clinician.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R W Brower, G T Meester, C Zeelenberg, P G Hugenholtz. 1977. Automatic data processing in the cardiac catheterization laboratory.. https://doi.org/10.1016/0010-468x(77)90016-2

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.

OBJECTIVES: We performed Holter monitoring on days 4 and 7 after acute myocardial infarction in 109 patients to assess whether ST segment shift would identify those with more severe coronary artery disease, left ventricular dysfunction and unfavorable prognosis. BACKGROUND: Silent myocardial ischemia is a frequent and prognostically significant event after acute myocardial infarction. However, the specific pathophysiologic mechanisms and the impact of thrombolytic therapy are uncertain. METHODS: In addition to Holter monitoring, patients underwent exercise testing, radionuclide angiography on days 1 and 9 and quantitative coronary angiography on day 9. RESULTS: Thirty-five patients (32%) had ST segment depression and had similar recombinant tissue-type plasminogen activator (rt-PA) treatment assignment and a reduced cross-sectional area of the infarct-related artery (0.59 +/- 0.57 vs. 1.04 +/- 1.26 mm2, p < 0.05). Global left ventricular function improved from day 1 to day 9 in patients without (4% +/- 11%, p < 0.001) but not in those with (0% +/- 7%) ST segment depression. In-hospital event rates were similar; however, follow-up 18 +/- 11 months after hospital discharge revealed a greater frequency of death and recurrent myocardial infarction in patients with compared with those without ST segment depression (27% vs. 6%, p = 0.03). CONCLUSIONS: After acute myocardial infarction, approximately one third of patients have ST segment depression on Holter monitoring, independent of the use of thrombolytic therapy. The unfavorable prognosis observed in these patients may be related to greater lumen obstruction in the infarct-related artery and lack of improvement in left ventricular function.

Cardiac Catheterization